Glucocorticoid-induced osteoporosis in patients with sarcoidosis

American Journal of the Medical Sciences

Volumn 325, Issue 1, 2003, Pages 1-6

  Adler, Robert A ^a   Funkhouser, Holly L ^a   Petkov, Valentina I ^a   Berger, Meredith M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Densitometry; Osteoporosis; Sarcoidosis; Vitamin D; X ray

Indexed keywords

CALCIUM; GLUCOCORTICOID; SEX HORMONE; VITAMIN D;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DENSITOMETRY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; MALE; MULTIPLE REGRESSION; OSTEOPOROSIS; OXYGEN THERAPY; PREDICTION; PROSPECTIVE STUDY; RISK FACTOR; SARCOIDOSIS; TESTOSTERONE BLOOD LEVEL; URINALYSIS; VITAMIN SUPPLEMENTATION;

EID: 0037235178     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200301000-00001     Document Type: Article

References (14)

1. 3 produced by culture alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab 1985;60:960-6.
2. Rottoli P, Gonnelli S, Solitro S, et al. Alterations in calcium metabolism and bone mineral density in relation to the activity of sarcoidosis. Sarcoidosis 1993;10:161-2.
3. Rizzato G, Ribouldi A, Imbimbo B, et al. The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis. Respir Med 1997;91:449-60.
4. Guralnik JM, Simonsick EM, Ferucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49:M85-M94.
5. Sambrook P, Birmingham J, Kelly P, et al. Prevention of corticosteroid induced osteoporosis - a comparison of calcium, calcitriol, and calcitonin. N Engl J Med 1993;328:1747-52.
6. Conron M, Young C, Beynon HLC. Calcium metabolism in sarcoidosis and its clinical implications. Rheumatology 2000;39:707-13.
7. Rizzato G. Clinical impact of bone and calcium metabolism changes in sarcoidosis. Thorax 1998;53:42-9.
8. Adler RA, Rosen CJ. Glucocorticoids and osteoporosis. Endocrinol Metab Clin North Am 1994;23:641-54.
9. Barre PE, Gascon-Barre M, Meakins JL, et al. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Am J Med 1987;82:1259-62.
10. Bell NH, Yergey AL, Vieira NE, et al. Demonstration of a difference in urinary calcium, not calcium absorption, in black and white adolescents. J Bone Miner Res 1993;8:1111-5.
11. Iqbal F, Michaelson J, Thaler L, et al. Declining bone mass in men with chronic pulmonary disease. Chest 1999;116:1616-24.
12. Incalzi RA, Caradonna P, Ranieri P, et al. Correlates of osteoporosis in chronic pulmonary disease. Respir Med 2000;94:1079-84.
13. Adler RA, Funkhouser HL, Petkov VI, et al. Osteoporosis in pulmonary clinic patients: does point of care screening predict central dual energy x-ray absorptiometry? Chest, in press.
14. Gonnelli S, Rottoli P, Cepollaro C et al. Prevention of corticosteroid induced osteoporosis with alendronate in sarcoid patients. Calcif Tissue Int 1997;61:382-5.